TRM cells producing IL-17A in resolved psoriasis epidermis could be associated with early relapse (148), and CD8+ TRM cells with IL-17A-producing potential in disease-naïve, non-lesional sites possibly correlate with disease duration (138). Here, CD8A is linked to psoriasis.